And another one
It’s all about the vaccine, says NAB’s Rodrigo Catril, as Moderna announces successful trials, with the markets ignoring the likely economic hit for Q3 and Q4.
It’s all about the vaccine, says NAB’s Rodrigo Catril, as Moderna announces successful trials, with the markets ignoring the likely economic hit for Q3 and Q4.